Dale Chappell

Insider Reports History

Reporting-owner location: Dolores, CO
Latest reporting-owner signature: BLACK HORSE CAPITAL LP By: Black Horse Capital Management LLC, its Managing General Partner By: /s/ Geoff Winkler Name: Geoff Winkler Title: Authorized Person
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Dale Chappell

Form 4 holding Chief Scientific Officer, Director, 10%+ Owner

HUMANIGEN, INC

Security class: Common Stock, $0.001 par value
Shares / value: 8,398,871
Estimated value: $92,388
Report date: 18 Oct 2023
Price: $0.0110
Ownership: By Cheval Holdings, Ltd.

Form 4 holding Chief Scientific Officer, Director, 10%+ Owner

HUMANIGEN, INC

Security class: Common Stock, $0.001 par value
Shares / value: 2,307,530
Estimated value: $25,383
Report date: 18 Oct 2023
Price: $0.0110
Ownership: By Black Horse Capital Master Fund Ltd.

Form 4 holding Chief Scientific Officer, Director, 10%+ Owner

HUMANIGEN, INC

Security class: Common Stock, $0.001 par value
Shares / value: 1,041,536
Estimated value: $11,457
Report date: 18 Oct 2023
Price: $0.0110
Ownership: By Black Horse Capital LP

Insider Reports Filed by Dale Chappell

HUMANIGEN, INC

Report period: 18 Oct 2023
Transactions: 3
Transaction value: -$4,250
Accepted by SEC: 20 Oct 2023, 18:50
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 27 Jul 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Jul 2022, 18:31
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 18 May 2022
Transactions: 9
Transaction value: +$2,263,991
Accepted by SEC: 20 May 2022, 17:57
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 11 Mar 2022
Transactions: 3
Transaction value: +$3,000,000
Accepted by SEC: 15 Mar 2022, 18:23
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 08 Mar 2022
Transactions: 12
Transaction value: +$4,663
Accepted by SEC: 10 Mar 2022, 18:24
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 02 Mar 2022
Transactions: 15
Transaction value: +$5,874
Accepted by SEC: 04 Mar 2022, 17:42
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 12 Jan 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Jan 2022, 16:06
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 31 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2022, 17:20
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 30 Sep 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Oct 2021, 20:07
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 11 Aug 2021
Transactions: 6
Transaction value: -$2,859,709
Accepted by SEC: 13 Aug 2021, 21:28
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 28 Jul 2021
Transactions: 6
Transaction value: -$665,866
Accepted by SEC: 30 Jul 2021, 21:01
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 21 Jul 2021
Transactions: 9
Transaction value: -$5,403,074
Accepted by SEC: 23 Jul 2021, 20:32
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 14 Jul 2021
Transactions: 3
Transaction value: -$258,847
Accepted by SEC: 16 Jul 2021, 20:28
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 08 Jul 2021
Transactions: 6
Transaction value: -$5,966,878
Accepted by SEC: 09 Jul 2021, 21:01
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 30 Jun 2021
Transactions: 9
Transaction value: -$7,959,379
Accepted by SEC: 02 Jul 2021, 17:44
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 23 Jun 2021
Transactions: 9
Transaction value: -$22,801,514
Accepted by SEC: 25 Jun 2021, 21:01
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 16 Jun 2021
Transactions: 9
Transaction value: -$14,000,186
Accepted by SEC: 21 Jun 2021, 20:57
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 07 Jun 2021
Transactions: 3
Transaction value: -$1,538,793
Accepted by SEC: 09 Jun 2021, 16:45
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

HUMANIGEN, INC

Report period: 02 Jun 2021
Transactions: 9
Transaction value: -$7,304,993
Accepted by SEC: 04 Jun 2021, 18:07
Role: Chief Scientific Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Dale Chappell

Insider Reports Filed by Dale Chappell